Stock listing
Stuttgart:PHGN Pharming Group NV Aktie
German listing (Stuttgart) of Pharming Group NV · home listing Euronext:PHARM
Follow Pharming Group NV into a list and get an email when it puts out news.
Share price · SWB:PHGN
€1.07 EUR -0.04 (-3.4%)
Close on Nov 5, 2026
- Day range
- €1.07 – €1.13 EURNov 5, 2026
- Volume
- 2,437 sharesNov 5, 2026
- 52-week range
- €0.82 – €1.80 EURLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- €8,726 EURMedian day 500 shares · 29 days with no trades · last 3 months, Aug 5, 2026 – Nov 5, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:PHARM · Home | €1.117 EUR | -0.004 (-0.4%) | 4,519,835 | €1.12 | €1.134 | €1.113 | €1.122 | Close on Nov 18, 2026 |
| NASDAQ:PHAR | $12.06 USD | -0.53 (-4.2%) | 8,319 | $12.26 | $12.35 | $12.06 | $12.59 | Close on Nov 17, 2026 |
| OTC:PHGUF | $1.26 USD | 0.00 (0.0%) | — | $1.26 | $1.26 | $1.26 | $1.26 | Close on Nov 6, 2026 |
| Frankfurt:PHG | €10.90 EUR | -0.30 (-2.7%) | — | €10.90 | €11.10 | €10.90 | €11.20 | Close on Nov 17, 2026 |
| Stuttgart:PHGN | €1.068 EUR | -0.038 (-3.4%) | 2,437 | €1.103 | €1.132 | €1.068 | €1.106 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · SWB:PHGN · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €1.068 | -0.038 | -3.4% | €1.103 | €1.132 | €1.068 | 2,437 | |
| €1.106 | -0.018 | -1.6% | €1.125 | €1.146 | €1.091 | 500 | |
| €1.124 | -0.002 | -0.2% | €1.092 | €1.13 | €1.082 | 0 | |
| €1.127 | +0.05 | +4.7% | €1.134 | €1.137 | €1.111 | 449 | |
| €1.076 | +0.005 | +0.4% | €1.068 | €1.096 | €1.066 | 0 | |
| €1.072 | -0.005 | -0.4% | €1.077 | €1.102 | €1.072 | 0 | |
| €1.076 | 0.00 | 0.0% | €1.074 | €1.101 | €1.067 | 130 | |
| €1.077 | +0.031 | +3.0% | €1.041 | €1.096 | €1.041 | 1,197 | |
| €1.046 | +0.036 | +3.5% | €1.026 | €1.063 | €1.013 | 1,020 | |
| €1.01 | +0.072 | +7.7% | €0.936 | €1.021 | €0.923 | 5,050 | |
| €0.938 | +0.094 | +11.1% | €0.843 | €0.95 | €0.843 | 12,950 | |
| €0.844 | +0.001 | +0.2% | €0.843 | €0.848 | €0.833 | 0 | |
| €0.843 | +0.023 | +2.8% | €0.82 | €0.85 | €0.82 | 11,070 | |
| €0.82 | -0.014 | -1.6% | €0.837 | €0.84 | €0.82 | 0 | |
| €0.834 | -0.025 | -2.9% | €0.862 | €0.865 | €0.83 | 0 | |
| €0.859 | +0.008 | +0.9% | €0.846 | €0.86 | €0.845 | 0 | |
| €0.851 | +0.005 | +0.6% | €0.845 | €0.90 | €0.845 | 0 | |
| €0.846 | -0.021 | -2.4% | €0.867 | €0.875 | €0.843 | 0 | |
| €0.867 | -0.006 | -0.7% | €0.875 | €0.892 | €0.856 | 0 | |
| €0.873 | +0.022 | +2.5% | €0.855 | €0.88 | €0.852 | 0 | |
| €0.851 | -0.004 | -0.5% | €0.854 | €0.854 | €0.841 | 0 | |
| €0.855 | -0.003 | -0.4% | €0.857 | €0.864 | €0.852 | 20,000 | |
| €0.858 | -0.014 | -1.6% | €0.866 | €0.89 | €0.858 | 11,000 | |
| €0.873 | +0.003 | +0.3% | €0.866 | €0.88 | €0.866 | 0 | |
| €0.87 | -0.01 | -1.1% | €0.882 | €0.883 | €0.865 | 15 | |
| €0.88 | -0.003 | -0.4% | €0.885 | €0.89 | €0.862 | 0 | |
| €0.884 | -0.008 | -0.9% | €0.894 | €0.90 | €0.877 | 11,000 | |
| €0.891 | -0.031 | -3.4% | €0.89 | €0.907 | €0.84 | 26,363 | |
| €0.922 | +0.011 | +1.2% | €0.906 | €0.932 | €0.906 | 0 | |
| €0.911 | -0.004 | -0.5% | €0.915 | €0.927 | €0.906 | 102,328 | |
| €0.915 | -0.023 | -2.5% | €0.943 | €0.943 | €0.91 | 0 | |
| €0.939 | -0.019 | -2.0% | €0.961 | €0.965 | €0.931 | 0 | |
| €0.958 | +0.034 | +3.7% | €0.94 | €0.97 | €0.937 | 41,200 | |
| €0.924 | +0.013 | +1.4% | €0.916 | €0.931 | €0.908 | 6,000 | |
| €0.911 | -0.019 | -2.0% | €0.929 | €0.948 | €0.91 | 2,174 | |
| €0.93 | +0.016 | +1.7% | €0.916 | €0.941 | €0.914 | 0 | |
| €0.915 | +0.006 | +0.6% | €0.911 | €0.927 | €0.911 | 0 | |
| €0.909 | -0.025 | -2.7% | €0.932 | €0.933 | €0.904 | 0 | |
| €0.934 | -0.024 | -2.5% | €0.971 | €0.975 | €0.922 | 22,500 | |
| €0.958 | +0.043 | +4.7% | €0.931 | €0.958 | €0.913 | 62,963 | |
| €0.915 | -0.027 | -2.8% | €0.945 | €0.955 | €0.915 | 1,500 | |
| €0.942 | -0.024 | -2.5% | €0.963 | €0.967 | €0.942 | 0 | |
| €0.966 | -0.012 | -1.2% | €0.978 | €0.987 | €0.966 | 0 | |
| €0.978 | +0.016 | +1.7% | €0.961 | €0.981 | €0.961 | 0 | |
| €0.962 | -0.004 | -0.4% | €0.967 | €0.982 | €0.957 | 3,046 | |
| €0.966 | +0.002 | +0.2% | €0.964 | €0.985 | €0.964 | 4,092 | |
| €0.964 | 0.00 | 0.0% | €0.964 | €0.991 | €0.958 | 0 | |
| €0.964 | -0.03 | -3.0% | €0.996 | €1.00 | €0.958 | 1,181 | |
| €0.994 | +0.005 | +0.5% | €0.99 | €0.994 | €0.984 | 100 | |
| €0.989 | -0.015 | -1.5% | €1.014 | €1.016 | €0.989 | 0 | |
| €1.004 | +0.006 | +0.6% | €1.003 | €1.015 | €1.003 | 0 | |
| €0.998 | -0.001 | -0.1% | €1.013 | €1.015 | €0.998 | 0 | |
| €0.999 | +0.008 | +0.8% | €0.993 | €1.009 | €0.977 | 1,329 | |
| €0.991 | -0.017 | -1.7% | €1.009 | €1.014 | €0.98 | 25,000 | |
| €1.008 | +0.02 | +2.1% | €0.99 | €1.015 | €0.99 | 3,210 | |
| €0.988 | -0.013 | -1.3% | €1.002 | €1.022 | €0.987 | 0 | |
| €1.001 | +0.014 | +1.4% | €0.985 | €1.021 | €0.984 | 750 | |
| €0.987 | -0.029 | -2.8% | €1.013 | €1.022 | €0.987 | 800 | |
| €1.016 | +0.022 | +2.3% | €0.995 | €1.022 | €0.991 | 0 | |
| €0.994 | -0.029 | -2.9% | €1.02 | €1.023 | €0.99 | 20,000 | |
| €1.023 | +0.012 | +1.2% | €1.001 | €1.042 | €1.001 | 70,000 | |
| €1.011 | +0.028 | +2.9% | €0.984 | €1.011 | €0.969 | 2,381 | |
| €0.982 | +0.031 | +3.2% | €0.952 | €0.992 | €0.941 | 37,949 | |
| €0.951 | -0.002 | -0.3% | €0.965 | €0.965 | €0.942 | 42,062 | |
| €0.954 | +0.016 | +1.7% | €0.938 | €0.967 | €0.906 | 550 | |
| €0.938 | +0.007 | +0.7% | €0.932 | €0.948 | €0.92 | 1,075 | |
| €0.931 | +0.029 | +3.2% | €0.901 | €0.932 | €0.901 | 61,800 |
Splits
1 split · SWB:PHGN · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- Stuttgart:PHGN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
What changed lately
Latest news release · Nov 6, 2026
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Latest earnings call · Jul 30, 2026
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 40 slides
Calls
Replays
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
Oct 27, 2026
Closed €1.08 (+3.0%) on Oct 27, 2026
Pharming Group announces third quarter 2026 revenues above market expectations
Oct 22, 2026
Closed €0.938 (+11.1%) on Oct 22, 2026
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
Oct 14, 2026
Closed €0.851 (+0.6%) on Oct 14, 2026
Pharming announces CEO transition
Sep 29, 2026
Closed €0.891 (-3.4%) on Sep 29, 2026
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
Sep 25, 2026
Closed €0.922 (+1.2%) on Sep 28, 2026
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
Sep 22, 2026
Closed €0.958 (+3.7%) on Sep 22, 2026
FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.
Sep 14, 2026
Closed €0.909 (-2.7%) on Sep 15, 2026
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
Sep 11, 2026
Closed €0.934 (-2.5%) on Sep 14, 2026
Pharming Group to participate in September investor conferences
Sep 9, 2026
Closed €0.942 (-2.5%) on Sep 9, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 40 slides · November 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 41 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
Pharming Group NV on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 55 in all · newest Nov 6, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Jul 30, 2026
- Decks
- 85 decks · latest November 2026
Where Pharming Group NV is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:PHARM · Home listing | Euronext | Netherlands | EUR |
| NASDAQ:PHAR | NASDAQ | United States | USD |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| LSIN:0QCO | LSIN | United Kingdom | EUR |
| gettex:PHGN | gettex | Germany | EUR |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| Tradegate:PHGN | Tradegate | Germany | EUR |
| Xetra:PHGN | Xetra | Germany | EUR |
| LS Exchange:A1H65A | LS Exchange | Germany | EUR |
| OTC:PHGUF | OTC | United States | USD |
| BOATS:PHAR | BOATS | United States | USD |
| Turquoise:PHARMA | Turquoise | United Kingdom | EUR |
| gettex:PHG | gettex | Germany | EUR |
| Lang & Schwarz:A1H65A | Lang & Schwarz | Germany | EUR |
| Frankfurt:PHGN | Frankfurt | Germany | EUR |
| Hamburg:PHGN | Hamburg | Germany | EUR |
| Stuttgart:PHG | Stuttgart | Germany | EUR |
| BX Swiss:PHGN | BX Swiss | Switzerland | CHF |
| Dusseldorf:PHGN | Dusseldorf | Germany | EUR |
| Frankfurt:PHG | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QLQY | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QLQY | LS Exchange | Germany | EUR |
| Munich:PHGN | Munich | Germany | EUR |
| Dusseldorf:PHG | Dusseldorf | Germany | EUR |
| Munich:PHG | Munich | Germany | EUR |
| Stuttgart:PHGN · This page | Stuttgart | Germany | EUR |
| Hanover:PHGN | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Pharming Group NV.